Instructions / Instruction for use: AlimemazineI want this, give me price
Latin name of substance Alimemazine
Alimemazinum (genus. Alimemazini)
N, N, beta-Trimethyl-10H-phenothiazine-10-propanamine (and as a tartrate)
The nosological classification (ICD-10)
F23.9 Acute and transient psychotic disorder, unspecified: Psychotic disorder; Somatized Mental Disorder; Acute psychotic disorder; Reactive psychosis
F32 Depressive episode: Adynamic subdepression; Astheno-adynamic subdepressive states; Asthenoadressive disorder; Astheno-depressive disorder; Asthenodepressive state; Astheno-depressive state; Major Depressive Disorder; Vyaloapatichesky depression with retardation; Double Depression; Depressive pseudodement; Depressive illness; Depressive mood disorder; Depressive disorder; Depressive mood disorder; Depressive state; Depressive disorders; Depressive syndrome; Depressive syndrome larviated; Depressive syndrome in psychoses; Depressed mask; Depression; Depression Depletion; Depression with the phenomena of inhibition within the framework of cyclothymia; Depression is smiling; Involutional depression; Involutionary melancholy; Involutional depression; Manic-depressive disorder; Masked Depression; Melancholic Attack; Neurotic depression; Neurotic depression; Shallow Depression; Organic depression; Organic depressive syndrome; Simple depression; Simple melancholic syndrome; Psychogenic depression; Reactive depression; Reactive depression with moderate psychopathological symptoms; Reactive depressive states; Reactive depression; Recurrent depression; Seasonal depressive syndrome; Severostatic depression; Senile Depression; Senile Depression; Symptomatic Depression; Somatogenic depression; Cyclotymic depression; Exogenous depression; Endogenous depression; Endogenous Depressive Conditions; Endogenous Depression; Endogenous depressive syndrome
F41.2 Mixed anxiety and depressive disorder: Depression with anxiety-depressive components; Mixed anxiety-depressive conditions;Anxiety Depression; Anxious and depressing mood; Anxiety-depressive state; Anxious-depressive conditions; Anxiety-depressive syndrome; Anxious-Neurotic Conditions
F41.9 Anxiety disorder, unspecified: Neurotic disorders with anxiety syndrome; Severe anxiety; Neurosis-like symptoms; Neuro-like disorders; Neuro-like conditions; Neuroses with anxiety symptoms; Neuroses with a sense of anxiety; Acute situational and stress anxiety; Acute attack of anxiety; Abrupt anxiety; Situational Anxiety Disorder; State of anxiety; Anxious-delirious component; Alarming state; Anxiety; Anxiety Disorders; Anxiety syndrome; Sense of anxiety; Alarm states; Chronic neurotic anxiety; Susto; Psychopathy with a predominance of anxiety and anxiety; Anxiety disorders in neurotic and neurosis-like states; Anxious neuroses; Anxious and delusional state; Acute situational stress alarm; Depressed mood with elements of anxiety
F45.0 Somatic disorder: Briquet syndrome
F48.9 Neurotic disorder, unspecified: Neurosis; Secondary neurotic symptom; Other neurotic conditions; Neurosis with increased irritability; Neuroses; Neuroses of all kinds; Neuroses with retardation; Neuroses of the heart; Neurotic disorders in alcoholism; Neurotic disorders with retardation; Neurotic disorders with anxiety syndrome; Neurotic reactions; Neurotic symptoms with alcoholism; Neurotic states; Neurotic syndrome; Neurotic disorder; Attack of neurological dysfunction; School neurosis; Emotional Stress
F60.2 Dissocial personality disorder: Antisocial personality; Psychopathic personality; Psychopathy; Psychopathy of an excitable type; Psychopathy and psychopathic conditions; Psychopathy of hysterical type; Psychopathy with a predominance of anxiety and anxiety; Braking personality
G47.0 Sleep disturbance and sleep disturbances [insomnia]: Insomnia; Insomnia, especially the difficulty of falling asleep; Desynchronosis; Prolonged sleep disorder; Difficulty falling asleep; Insomnia; Short-term and transient sleep disorders; Short-term and chronic sleep disorders; Short or shallow sleep; Disturbance of falling asleep; Sleep disturbance, especially in the phase of falling asleep; Sleep disturbances; Sleep Disorders; Neurotic sleep disorder; Shallow shallow sleep; Shallow sleep; Unsatisfactory quality of sleep; Night Awakening; The pathology of sleep; Postmodern violation; Transient insomnia; Problems with falling asleep; Early Awakening; Early morning awakening; Early Awakenings; Sleep disorder; Persistent insomnia; Difficult to fall asleep; Difficulty falling asleep in children; Difficulty falling asleep; Persistent insomnia; Deterioration of sleep Chronic insomnia; Frequent nocturnal and / or early morning awakenings; Frequent nocturnal awakenings and a feeling of shallow sleep; Night Awakenings
R45.1 Anxiety and agitation: Agitation; Anxiety; Explosive excitability; Internal stimulation; Excitability; Excitation; Excitation acute; Psychomotor agitation; Hyperexcitability; Motor excitement; Cessation of psychomotor agitation; Nervous excitement; Restlessness; Night trouble; Acute stage of schizophrenia with agitation; Acute mental agitation; Paroxysm of excitation; Overexcitation; Increased excitability; Increased nervous excitability; Increased emotional and cardiac excitability; Increased agitation; Mental arousal; Psychomotor agitation; Psychomotor agitation in psychoses; Psychomotor agitation of an epileptic nature; Psychomotor paroxysm; Psychomotor fit; Symptoms of Excitation; Symptoms of psychomotor agitation; The state of agitation; A state of anxiety; Excitation status; A state of heightened concern; The state of psychomotor agitation; Conditions of anxiety; Excitation conditions; The state of excitement in somatic diseases; Excitation level; Feelings of anxiety; Emotional arousal
R45.8 Other symptoms and signs relating to the emotional state: State of confusion; Violation of the emotional-volitional sphere; Emotional disorders; Yearning; Lack of emotionality and avoidance of communication; Sense of anxiety; Autoaggression; Violations of the emotional-volitional sphere; Affective stupidity; Depressed mood with elements of anxiety
T78.4 Allergy, unspecified: Allergic reaction to insulin; Allergic reaction to insect bites; An allergic reaction similar to systemic lupus erythematosus; Allergic diseases; Allergic diseases of mucous membranes; Allergic diseases and conditions caused by increased release of histamine; Allergic diseases of mucous membranes; Allergic manifestations; Allergic manifestations on the mucous membranes; Allergic reactions; Allergic reactions caused by insect bites; Allergic reactions; Allergic conditions; Allergic edema of the larynx; Allergic disease; Allergic condition; Allergy; Allergy to house dust; Anaphylaxis; Skin reaction to medication; Skin reaction to insect bites; Cosmetic Allergy; Medicinal allergy; Medication allergy; Acute allergic reaction; Laryngeal edema of allergic origin and on the background of irradiation; Food and drug allergy
Characteristics of the substance Alimemazine
The phenothiazine derivative. A white or slightly yellowish crystalline powder, soluble in water and alcohol.
Pharmacological action - antihistamine, neuroleptic, antiemetic, sedative.
The antipsychotic effect is due to the blockade of dopamine D2 receptors of the mesolimbic and mesocortical system. Sedative action is due to blockade of adrenoreceptors of the reticular formation of the brainstem; antiemetic action - blockade of D2-receptors in the trigger zone of the vomiting center; hypothermic action - blockade of dopamine receptors of the hypothalamus. The effect develops 15-20 minutes after administration and lasts for 6-8 hours. It has low antipsychotic activity, therefore it is ineffective in acute psychotic conditions.
After oral administration, it is rapidly and completely absorbed from the digestive tract, Cmax in plasma is observed after 1-2 hours. Binding to plasma proteins is 20-30%. T1 / 2 - 3,5-4 hours. In the liver it is oxidized with the formation of a sulfoxide. It is excreted mostly with urine (within 2 days, about 70-80% is excreted).
Application of Alimamazine
Neuroses and neurosis-like conditions of endogenous and organic genesis with predominance of the senestopathic, hypochondriacal, phobic and psycho vegetative disorders; psychopathy with asthenic or psychoasthenic disorders; anxiety-depressive states in the framework of borderline endogenous and vascular diseases; senestropical depression; somatized mental disorders; state of anxiety and anxiety in somatic diseases; sleep disorders of various genesis, allergic reactions (symptomatic treatment).
Hypersensitivity, zakratougolnaya glaucoma, prostatic hyperplasia, severe liver and kidney damage, Parkinsonism, myasthenia gravis, Reye syndrome, concurrent use of MAO inhibitors, pregnancy, breastfeeding, age to 7 years.
Restrictions on the use
Chronic alcoholism, if there is an indication in the anamnesis of complications with the use of preparations phenothiazine series; obstruction of the neck of the bladder; predisposition to urinary retention; epilepsy; open-angle glaucoma; jaundice; oppression of bone marrow function; arterial hypotension.
Side effects of the substance Alimemazine
From the nervous system and sense organs: dizziness, drowsiness, lethargy, fatigue, paradoxical reaction (anxiety, agitation, nightmarish dreams, irritability); rarely - confusion, extrapyramidal disorders (hypokinesia, akathisia, tremor); increased nighttime apnea, increased convulsive activity (in children), blurred vision (paresis of accommodation), noise or ringing in the ears.
From the cardiovascular system and blood (hematopoiesis, hemostasis): a decrease in blood pressure, tachycardia.
On the part of the intestine: dry mouth, atony of the digestive tract, constipation, decreased appetite.
On the part of the respiratory system: dryness in the nose, pharynx, increase in the viscosity of bronchial secretions.
From the genitourinary system: atony of the bladder, urine retention.
Other: allergic reactions, oppression of bone marrow hematopoiesis, increased sweating, muscle relaxation, photosensitivity.
Strengthens the effects of narcotic analgesics, hypnotics, anxiolytics, other neuroleptics, drugs for general anesthesia, m-holinoblokatorov and antihypertensive drugs (requires dose adjustment). Weaken the action of derivatives of amphetamine, m-cholinomimetics, ephedrine, guanethidine, levodopa, dopamine. When combined with drugs that suppress the functions of the central nervous system, incl. ethanol - increased oppression of the central nervous system, with anti-epileptic drugs and barbiturates - lowering the threshold of convulsive readiness (requires dose adjustment). Weaken the effect of bromocriptine and increase the concentration of prolactin in the serum.
Beta-adrenoblokatory increase (mutually) the concentration of alimamazine in the plasma (possibly a marked decrease in blood pressure, arrhythmia). Tricyclic antidepressants and anticholinergic drugs increase the m-cholinoblocking activity of alimamazine. MAO inhibitors (concurrent use is not recommended) and other phenothiazine derivatives increase the risk of arterial hypotension and extrapyramidal disorders.
With the simultaneous administration of alimamazine with drugs that inhibit bone marrow hematopoiesis, the risk of myelosuppression increases. Hepatotoxic drugs increase the manifestation of hepatotoxicity of the drug.
Symptoms: increased severity of adverse reactions, depression of consciousness.
Routes of administration
Precautions for the substance Alimemazine
With prolonged treatment, it is necessary to systematically carry out a general blood test, evaluate liver function.
Can mask the ototoxic effect (tinnitus and dizziness) of shared drugs. Increases the need for riboflavin.
To prevent distortion of skin scarification test results for allergens, it is necessary to cancel the drug for 72 hours before allergological testing. During treatment, false-positive pregnancy test results are possible. During the treatment should not drink alcohol. With caution appoint drivers of transport and persons working with potentially dangerous mechanisms.